New I-Site Plus Tablet

Short Description

New I-Site Plus Tablet is a medication used to manage Diabetic Retinopathy, Asthenopia, and accommodative Insufficiency.

Dosage Form

Tablet

Introduction

New I site plus is a tablet used to manage Diabetic Retinopathy, Asthenopia, and accommodative Insufficiency. It contains a combination of astaxanthin, lutein, zeaxanthin, resveratrol, Docosahexanoic acid (DHA), copper, zinc, and tocotrienol. The key benefits of New I site plus include antioxidant properties, improved accommodative ability, reduced oxidative stress, and improved visual acuity, contrast sensitivity, and macular edema in DR patients.

New I site Plus is recommended once daily in adults.

The exact mechanism of action of New I site plus is not specified, but it is believed to work by reducing oxidative stress, inhibiting inflammation, and improving blood flow in the retinal capillaries.